# Differential Target Multiplexed Spinal Cord Stimulation (DTM-SCS®) Real World Outcomes

> **NCT04725838** · — · COMPLETED · sponsor: **Celéri Health, Inc.** · enrollment: 255 (actual)

## Conditions studied

- Chronic Pain

## Interventions

- **DEVICE:** Medtronic Intellis™ and Vanta™

## Key facts

- **NCT ID:** NCT04725838
- **Lead sponsor:** Celéri Health, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-29
- **Primary completion:** 2023-07-01
- **Final completion:** 2023-07-01
- **Target enrollment:** 255 (ACTUAL)
- **Last updated:** 2024-08-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04725838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04725838, "Differential Target Multiplexed Spinal Cord Stimulation (DTM-SCS®) Real World Outcomes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04725838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*